Corey J. Wallach, MD

Biography

Corey J. Wallach, a native of Northern Virginia, is pleased to have returned to the area as a spine surgeon for the Anderson Clinic and to serve as the Medical Director for the INOVA Spine Institute in its eastern region, overseeing quality spine care at Alexandria and Mt. Vernon hospitals.

Dr. Wallach left Virginia to attend Columbia University, where he first studied Architecture and Religion before beginning his medical career. He attended medical school at the University of California, Davis, where he was honored with both the Lipscomb Award for Excellence in Orthopaedic Surgery and membership in the Alpha Omega Alpha Honor Society. He completed his residency at the University of Pittsburgh Medical Center, where he conducted extensive research on biologic treatment strategies for degenerative spinal disorders, earning national and international recognition for his efforts.

He returned to California for his spine fellowship at the prestigious UCLA Comprehensive Spine Center, which specializes in motion-preserving, minimally invasive, and traditional treatment strategies for cervical, thoracic, and lumbar pathology, working with both the orthopedic spine and neurosurgical spine care teams.

Since returning to Virginia, Dr. Wallach has been delighted to oversee the growth and development of spine care at the Anderson Clinic. Our spine center now addresses all aspects of spine care with an emphasis on conservative management and the latest in minimally invasive treatment options. We pride ourselves foremost on patient education and assist with physical therapy tailored to your unique spinal complaints and therapeutic and diagnostic spinal injections when necessary. If surgery is required, we utilize advanced techniques that allow for a rapid resolution of one’s pain, as well as a quick return to activities and independence. He has also been integral to the development and growth of the INOVA Spine Center while serving as the medical director for spine care at both INOVA Alexandria and Mt. Vernon hospitals, aiming to improve spine care for all patients in the northern Virginia region.

In keeping with his academic training, Dr. Wallach continues to be actively involved in clinical research aimed at improving spine care and lecturing nationally on various treatment options for spinal disorders. He has served on the board of directors for the American College of Spine Surgery, has chaired its educational curriculum, and recently served as the College’s President.

In his spare time, Dr. Wallach enjoys woodworking and guitar but mostly enjoys the company of his wife and three children.

Hospital Affiliations

INOVA Alexandria
INOVA Mount Vernon
Harborside Surgery Center

Videos

Publications

Lumbar chance fracture after direct anterior total hip arthroplasty. Pitta M, Wallach CJ, Bauk C, Hamilton WG. Arthroplast Today. 2017 Jul 10;3(4):247-250. doi: 10.1016/j.artd.2017.05.010. eCollection 2017 Dec.

Safety assessment of intradiscal gene therapy II: effect of dosing and vector choice. Levicoff EA, Kim JS, Sobajima S, Wallach CJ, Larson JW 3rd, Robbins PD, Xiao X, Juan L, Vadala G, Gilbertson LG, Kang JD. Spine (Phila Pa 1976). 2008 Jun 15;33(14):1509-16; discussion 1517. doi: 10.1097/BRS.0b013e318178866c.

Symposium. Potential strategies for improving orthopaedic education. Strategic dialogue from the AOA Resident Leadership Forum Class of 2005.

Ranawat AS, Dirschl DR, Wallach CJ, Harner CD. J Bone Joint Surg Am. 2007 Jul;89(7):1633-40. No abstract is available.

Safety assessment of intradiscal gene transfer: a pilot study. Wallach CJ, Kim JS, Sobajima S, Lattermann C, Oxner WM, McFadden K, Robbins PD, Gilbertson LG, Kang JD. Spine J. 2006 Mar-Apr;6(2):107-12.

A slowly progressive and reproducible animal model of intervertebral disc degeneration characterized by MRI, X-ray, and histology. Sobajima S, Kompel JF, Kim JS, Wallach CJ, Robertson DD, Vogt MT, Kang JD, Gilbertson LG. Spine (Phila Pa 1976). 2005 Jan 1;30(1):15-24.

Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglycans in cells from degenerated human intervertebral discs. Wallach CJ, Sobajima S, Watanabe Y, Kim JS, Georgescu HI, Robbins P, Gilbertson LG, Kang JD. Spine (Phila Pa 1976). 2003 Oct 15;28(20):2331-7.

Gene therapy applications for intervertebral disc degeneration. Wallach CJ, Gilbertson LG, Kang JD. Spine (Phila Pa 1976). 2003 Aug 1;28(15 Suppl):S93-8. Review.

Approaches for skeletal gene therapy. Niyibizi C, Wallach CJ, Mi Z, Robbins PD. Crit Rev Eukaryot Gene Expr. 2002;12(3):163-73. Review.